AMC
The Amcor (AMC) result is inline, and guidance matches street estimates for the full year.
It remains a decent inflation hedge (pass-throughs to end customer) against oil/energy, and trades at 15x.
Not bad for a reasonably low vol, growing, player of scale (and plastics packaging is all about size, it’s where the competitive advantage comes in).
Update:
AMC have noted that demand is slowing, and when asked about “why not lower your guidance” at the Q&A session, said it was simply because they were unsure about volumes, but felt that cost out could get them there.
Near term, that is obviously a wobbly answer and clearly a candidate for guidance revision (a downgrade).
It is very difficult to know what to do in that situation. The stock is on 15x, which is not particularly high, and, given we worry that global growth could slow given rate hikes, aren’t sure that other stocks have less earnings risk.
AMC also pointed to the fact that weakness stemmed from places like China, over October, November, December. But China reopened, and it is possible that China surprises to the upside. AMC noted that January was better than October-December.
So, it could disappoint, but, we would likely hold through a downgrade and add more, on material weakness.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.